Dr Carlos Martínez-Pérez (BSc, MSc, PhD)

Research Fellow

Biography

Background

Following an undergraduate degree in Biotechnology from the Polytechnic University of Valencia, I moved to the UK to study an MSc in Molecular Medicine in Cranfield University, followed by a PhD in Molecular and Clinical Medicine (Pathology) in the University of Edinburgh, working on a SULSA BioSkape industrial collaboration project focused on pre-clinical drug development in breast and ovarian cancers.

I am currently a Research Fellow in the Translational Oncology Research Group, at the University of Edinburgh's Institute of Genetics and Cancer.

Qualifications

  • PhD Molecular and Clinical Medicine (Pathology)

       Division of Pathology Laboratories, IGMM, University of Edinburgh – Awarded in March 2017

  • MSc(Res) Molecular Medicine

       Cranfield University (2011) - Awarded best student prize

  • BSc (Hons) Biotechnology

       Polytechnic University of Valencia (2010)

Undergraduate teaching

Course Organiser for Reproductive Cancers (BIME10037), Hons Elective in the Reproductive Biology BSc programme.

Postgraduate teaching

Course Organiser for Reproductive Tract Cancers (BIME11190), 2nd year Elective in the Cancer Biology and Precision Oncology online MSc programme.

Research summary

I work on translational breast cancer research. This approach integrates the work that goes on in the clinic and the laboratory, to try to bridge the gap between both. By focusing on researching the molecular cancer mechanisms linked to specific issues patients and doctors encounter daily, translational research can take results “from lab bench to beside”, directly addressing current and urgent clinical needs. 

Current research interests

I currently am a Research Fellow in the Translational Oncology Research Group, based at the University of Edinburgh's Institute of Genetics and Cancer. One of my main interests is the study of endocrine therapy resistance in ER+ breast cancer. By studying large cohorts of longitudinally-matched tumour samples, this work aims to conduct comprehensive, multiomics characterisation to understand how mechanisms that drive resistance and contribute to recurrence and disease upstaging emerge, and how they evolve over time.

Conference details

International Conferences

British Association for Cancer Research – Breast Cancer Conference 2024 - 2 posters

Edinburgh Next Generation of Genomics Symposium 2023 – oral presentation

San Antonio Breast Cancer Symposium (SABCS) 2023 - 2 posters

SABCS 2022 - spotlight discussion

SABCS 2019 - 6 posters

ESMO Breast Cancer Congress 2019 - poster

SABCS 2018 - 8 posters

SABCS 2017 - 4 posters

American Society of Clinical Oncology (ASCO) 2016 - poster

SABCS 2015 - 3 posters

SABCS 2014 - 2 posters and oral communication

National Conferences

Edinburgh Breast Cancer Special Symposium (EBCSS) 2021 - Member of the organising committee

EBCSS 2020 - Member of the organising committee & 7 posters

UK Interdisciplinary Breast Cancer Symposium (UK-IBCS) 2020 - 4 posters

BACR Special Conference 'New developments in Breast Cancer research' - 2 posters & 1 oral presentation

UK-IBCS 2018 - poster

Scottish Biomedical Postdoctoral Research Conference 2015 - poster and oral communication - awarded best poster prize

Beatson Institute Visualising Cancer Conference 2014 - oral communication

Biochemical Society Focused Meeting: Redox Regulation in Health & Disease 2014 - poster and oral communication

Scottish Universities Life Sciences Alliances (SULSA) annual symposium 2014 - 2 posters - awarded best overall poster prize

SULSA annual symposium 2013 - poster

Organiser

Edinburgh Breast Cancer Special Symposium (EBCSS) - Member of the organising committee in 2020 and 2021

Neoadjuvant Chemotherapy for the management of Breast Cancer - Clinical Training Day (2021) - Member of the organising committee

Endocrine Therapy for the management of Breast Cancer - Clinical Training Day (2020) - Member of the organising committee

This article was published on